Showing results (41-50 of 93) with videos related to
Sort By:
Pageof 10
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 11, 2017
Real-World Outcomes of Acute Ischemic Stroke Treatment with Intravenous Recombinant Tissue Plasminogen ActivatorKeith A Betts, Dana Hurley, Jinlin Song, et al.Current Medical Research and Opinion|October 3, 2022
Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraineRonan Mahon, Pamela Vo, Katharina Pannagl, et al.Future Oncology (London, England)|December 23, 2021
Temporal trends of adverse events and costs of nivolumab plus ipilimumab versus sunitinib in advanced renal cell carcinomaDaniel M Geynisman, Ella X Du, Xiaoran Yang, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 5, 2022
Real-world effectiveness of benralizumab: Results from the ZEPHYR 1 StudyYen Chung, Rohit Katial, Fan Mu, et al.Advances in Therapy|June 10, 2022
The Economic Burden of Eosinophilic Gastritis and Eosinophilic Enteritis in the United StatesMichael Woolley, Erin E Cook, Fan Mu, et al.Ophthalmology|July 11, 2017
Corticosteroid-Related Adverse Events Systematically Increase with Corticosteroid Dose in Noninfectious Intermediate, Posterior, or Panuveitis: Post Hoc Analyses from the VISUAL-1 and VISUAL-2 TrialsEric B Suhler, Jennifer E Thorne, Manish Mittal, et al.Journal of Comparative Effectiveness Research|October 8, 2020
US cost-effectiveness of polatuzumab vedotin, bendamustine and rituximab in diffuse large B-cell lymphomaKeith A Betts, Per-Olof Thuresson, Federico Felizzi, et al.Pharmacoeconomics - Open|November 6, 2024
Costs of Adverse Events in Patients with Advanced or Metastatic Renal Cell Carcinoma with First-Line TreatmentYan Chen, Ella X Du, Manasvi Sundar, et al.Advances in Therapy|August 24, 2019
Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial DataMorganna Freeman, Keith A Betts, Shan Jiang, et al.Clinical Genitourinary Cancer|September 4, 2024
Treatment Patterns and Survival Outcomes Among Androgen Receptor Pathway Inhibitor-Experienced Patients With Metastatic Castration-Resistant Prostate CancerVivek Narayan, Miraj Y Patel, Siguroli Teitsson, et al.Pageof 10